CMND Stock Analysis: Buy, Sell, or Hold?
CMND - Clearmind Medicine Inc. Common Shares
$1.62
0.01 (0.62%)
β²
5d:
-13.37%
30d:
-34.94%
90d:
+99.53%
HOLD
MODERATE Confidence
Analysis Updated: Jul 27, 2026 12:00 AM ET
Earnings: Sep 10, 2026
Get Alerted When CMND Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π HOLD: CMND shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
π HOLD: CMND shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CMND is currently trading at $1.62, which is considered oversold relative to its 30-day fair value range of $1.74 to $2.50.
Technical Outlook: Technically, CMND is in a uptrend. The price is currently testing key support at $1.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CMND has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CMND is in a uptrend. The price is currently testing key support at $1.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CMND has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.74 -
$2.50
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- CAUTION: 5-day price weakness (-13.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.74 -
$2.50
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.58
Resistance Level
$2.25
Current Trend
Uptrend
Technical data as of
Jul 27, 2026
Fundamental Context
Share & Embed Analysis
Last updated: July 28, 2026 1:10 AM ET
Data refreshes hourly during market hours. Next update: 2:10 AM
Data refreshes hourly during market hours. Next update: 2:10 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CMND showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ALNY
Alnylam Pharmaceuticals β¦ |
STRONG BUY
30 analysts |
$432 | 39 SELL |
|
VRTX
Vertex Pharmaceuticals I⦠|
BUY
34 analysts |
$555 | 54 HOLD |
|
LEGN
Legend BiotechΒ Corp |
STRONG BUY
22 analysts |
$54 | 50 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 53 HOLD |